Tag: Hypotrichosis

In some studies, over 70% of patients using the glaucoma drug latanoprost experienced hypertrichosis, or excessive eyelash growth, as a side effect [1.6.1, 1.6.6]. This has led to interest in how to use latanoprost for eyelash growth cosmetically, an application for which it is not FDA-approved [1.8.3].

Over 6 million units of the FDA-approved product for eyelash growth have been sold, but it isn't a pill. For individuals suffering from hypotrichosis, a condition characterized by inadequate eyelashes, the most effective and medically recognized treatment is a prescription topical solution containing bimatoprost. The notion of 'What pill makes your eyelashes grow?' is a common misconception, as the most potent treatments are applied directly to the lash line.

Originally approved by the FDA in 2008 for treating hypotrichosis of the eyelashes, the active ingredient bimatoprost was later studied for other areas, including eyebrows. So, **does bimatoprost make eyebrows grow**? While used off-label for this purpose, studies and clinical reports suggest it can increase eyebrow hair density and length.

In a clinical trial, 78% of Latisse® users saw a significant increase in eyelash prominence after 16 weeks [1.8.4]. This effectiveness raises the question: what is the difference between Latisse and bimatoprost, its active ingredient?

While FDA-approved specifically for eyelash hypotrichosis, bimatoprost's potential to grow eyebrows is widely discussed and supported by clinical evidence for its off-label use. The medication has been shown to increase eyebrow fullness and darkness, offering a solution for those with sparse or thinning brows.